NEW YORK--(BUSINESS WIRE)--Deerfield Healthcare Technology Acquisitions Corp. announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market and trade under the ticker symbol “DFHTU” beginning on July 17, 2020. Each unit consists of one share of Class A common stock and one-fifth of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “DFHT” and “DFHTW,” respectively. The offering is expected to close on July 21, 2020.

Deerfield Healthcare Technology Acquisitions Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company’s sponsor is an affiliate of Deerfield Management Company, L.P., an investment firm focused exclusively on the healthcare industry. While the Company may pursue an initial business combination opportunity in any business, industry, sector or geographical location, the Company intends to initially focus its search on identifying a prospective target business in the healthcare or healthcare-related industries in the United States and other developed countries. The Company’s strategy will be to identify, acquire and, after its initial business combination, build, a healthcare or healthcare related business. The Company intends to focus its investment effort broadly across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health. The Company plans to particularly focus its search for business combination targets in the life sciences, medical technology, digital health and technology-enabled services sectors.

Deutsche Bank Securities Inc. and UBS Securities LLC are acting as joint book-running managers of the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 1,875,000 units at the initial public offering price to cover over-allotments, if any.